To study the effect of hypervolemic hemodilution on cerebral blood flow (CBF).
- Hydroxyethylstarch Drug
Intervention Desc: Hemodiluting agent
Open, randomized, controlled trial of 27 patients.
12 patients were randomly allocated as controls without 10% hydroxyethylstarch (HES) infusion and 15 received 500 ml HES daily, infused over a period of 5-7 h, for 7 days.
|Type||Measure||Time Frame||Safety Issue|
|Primary||CBF was measured on days 1, 2 and 7 by the xenon 133 inhalation method.|